Rapamycin Treatment Improves Neuron Viability in an In Vitro Model of Stroke

Ischemic stroke is the leading cause of serious, long-term adult disability and is associated with sensorimotor and cognitive impairments due to neuronal degeneration. Currently, recombinant tissue plasminogen activator (rTPA) is the only FDA-approved medical therapy for treatment of patients with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fletcher, Lauren, Evans, Teresa M., Watts, Lora Talley, Jimenez, David F., Digicaylioglu, Murat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701663/
https://www.ncbi.nlm.nih.gov/pubmed/23861877
http://dx.doi.org/10.1371/journal.pone.0068281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701663/
https://www.ncbi.nlm.nih.gov/pubmed/23861877
http://dx.doi.org/10.1371/journal.pone.0068281

Ejemplares similares